| 2011 | 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
| CANCER |
| 2009 | 20대 이하 간세포암종의 증례 : 20세 미만의 젊은 연령에서 발병한 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
| 2022 | A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2020 | A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2011 | Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma | ONCOLOGY |
| 2020 | Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack | CEREBROVASCULAR DISEASES |
| 2019 | Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma | Journal of Vascular and Interventional Radiology |
| 2012 | Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma | LIVER INTERNATIONAL |
| 2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
| 2010 | Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. | CELL TRANSPLANTATION |
| 2010 | Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study | MAGNETIC RESONANCE IMAGING |
| 2015 | Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
| 2017 | Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2011 | Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2009 | Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2015 | Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2015 | Inter-observer variability of response evaluation criteria for hepatocellular carcinoma treated with chemoembolization | DIGESTIVE AND LIVER DISEASE |
| 2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
| 2006 | Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
| 2011 | Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| CELL TRANSPLANTATION |
| 2013 | Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
| CLINICAL CANCER RESEARCH |
| 2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
| 2008 | Prediction of microvascular invasion before curative resection of hepatocellular carcinoma | JOURNAL OF SURGICAL ONCOLOGY |
| 2012 | Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2009 | Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection
| YONSEI MEDICAL JOURNAL |
| 2015 | Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization | LIVER INTERNATIONAL |
| 2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
| 2013 | Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation | EUROPEAN JOURNAL OF CANCER |
| 2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2014 | Relationship Between Severity of Liver Dysfunction and the Relative Ratio of Liver to Aortic Enhancement (RE) on MRI Using Hepatocyte-Specific Contrast | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
| 2020 | The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
| GUT AND LIVER |
| 2022 | Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients
| CANCERS |
| 2017 | Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2004 | Treatment Outcome of Transcatheter Arterial Chemoinfusion According to Anticancer Agents and Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma (TNM Stage IVa)
| YONSEI MEDICAL JOURNAL |
| 2002 | 간문맥 혈전이 동반된 진행성 간세포암에서의 동시 항암 화학-방사선요법
| Korean Journal of Hepatology (대한간학회지) |
| 2005 | 간문맥종양혈전증을 동반한 간세포암종에서 반복적인 간동맥 내 항암약물주입요법의 효과
| Korean Journal of Hepatology (대한간학회지) |
| 2005 | 간세포암 환자에서 간동맥 화학색전술 후 발생한 급성 간부전의 위험인자
| Korean Journal of Medicine (대한내과학회지) |
| 2007 | 이차성 비기능항진증에서 부분적 비장동맥색전술의 장기 치료 효과
| Korean Journal of Medicine |
